Barry 3 - Bowie State 0 (VOLLEYBALL)

Bowie State vs Barry (Sep 6, 2013)

---

Box Score

---

Volleyball Box Score

Volleyball Box Score
BOWIE STATE UNIV. VOLLEYBALL 2013
Bowie State vs Barry
(Sep 6, 2013 at Shepherdstown, WV)

	Bowie State		ATTACK				SET	SERVE		SRV	DEF	BLOCK			GEN
##	Player	SP	K	E	TA	PCT	A	SA	SE	RE	DIG	BS	BA	BE	BHE	Points
2	MARTINEZ,Marissa	3	0	3	10	-.300	0	0	0	2	8	0	0	0	0	0.0
3	FINEY,Brelyn	3	1	2	9	-.111	0	0	1	0	0	0	2	1	0	2.0
4	JORDAN,Symone'	3	0	2	6	-.333	0	0	0	1	0	0	1	0	1	0.5
5	AFARI,Gennifer	3	0	2	3	-.667	0	0	0	1	0	0	0	0	0	0.0
6	FLOWERS,Briana	3	0	0	1	.000	1	0	0	0	0	1	0	0	1	1.0
8	JOHNSON,Antonique	3	0	0	2	.000	0	0	1	3	2	0	0	0	0	0.0
9	NGUNDAM,Yaje	3	0	4	8	-.500	0	0	0	3	11	0	0	2	0	0.0
12	FISHER,Alexis	3	0	2	5	-.400	0	0	2	2	1	0	3	1	0	1.5
14	TAYLOR,Regan	3	0	2	3	-.667	0	0	0	0	0	0	0	0	0	0.0
	LADY BULLDOGS									1
	Totals	3	1	17	47	-.340	1	0	4	13	22	1	6	4	2	5.0
							TOTAL TEAM BLOCKS: 4.0

TEAM ATTACK BY SET  Set  K  E  TA  Pct  Sideout  Pct  1  0  0  0  .000  0-0   0%  2  0  0  0  .000  0-0   0%  3  0  0  0  .000  0-0   0%            0-0   0%

SET SCORES  1  2  3     TEAM RECORDS  Bowie State   (0)  7  8  8     0-1   Barry   (3)  25  25  25     2-0

	Barry		ATTACK				SET	SERVE		SRV	DEF	BLOCK			GEN
##	Player	SP	K	E	TA	PCT	A	SA	SE	RE	DIG	BS	BA	BE	BHE	Points
1	Rachel Funk	1	0	0	0	.000	0	0	1	0	0	0	0	0	0	0.0
3	Jasmine Serna	3	0	0	0	.000	1	3	2	0	7	0	0	0	0	3.0
4	Jenny Trinidad	3	1	1	4	.000	28	5	2	0	6	1	0	0	4	7.0
5	Jayla Trombley	3	7	1	10	.600	0	0	1	0	5	0	0	0	0	7.0
6	Laine Cielena	3	7	0	13	.538	0	2	1	0	2	0	1	1	0	9.5
7	Katie Dooley	3	5	1	8	.500	0	1	1	0	0	0	0	1	0	6.0
8	Kristen Reid	3	1	0	2	.500	0	0	1	0	1	0	0	0	0	1.0
9	Mariana Ruiz	3	0	0	0	.000	0	0	1	0	2	0	0	0	0	0.0
10	Ivana Didanovic	3	5	1	9	.444	0	0	0	0	0	1	1	1	0	6.5
11	Amanda Brill	1	0	0	0	.000	0	1	0	0	0	0	0	0	0	1.0
13	Ashley Carrero	3	2	1	8	.125	0	1	1	0	3	0	0	0	0	3.0
15	Alex Wallace	3	3	0	5	.600	0	0	1	0	3	0	0	0	0	3.0
	Totals	3	31	5	59	.441	29	13	12	0	29	2	2	3	4	47.0
							TOTAL TEAM BLOCKS: 3.0

TEAM ATTACK BY SET  Set  K  E  TA  Pct  Sideout  Pct  1  0  0  0  .000  0-0   0%  2  0  0  0  .000  0-0   0%  3  0  0  0  .000  0-0   0%            0-0   0%		Site: Shepherdstown, WV (Butcher Center) Date: Sep 6, 2013 Attend: 35 Time: 1:02 Referees: Hampton Inn Ram Rumble (Shepherdstown, WV)

UDC Men's Soccer Erupts for Four Unanswered Goals in Season-Opening Win vs. Holy Family

 

September 6, 2013

Video | Recap | Box Score

Firebirds Erupt for Four Unanswered Goals in Season-Opening Win vs. Holy Family

Junior Byron Brown scored the Firebirds fourth unanswered goal in a convinving, 4-1 win.

FINAL	1	2	T
Holy Family (0-1)	1	0	1
Dist. Columbia (1-0)	3	1	4

SCORING SUMMARY
1st - 3:04	Justin Massaro (Holy Family)
1st - 10:16	Hernandez, Elio (Dist. Columbia)
1st - 12:10	Rowden, Sam (Dist. Columbia)
1st - 34:48	Angerer, Felix (Dist. Columbia)
2nd - 78:47	Brown, Byron (Dist. Columbia)

HOLY FAMILY	DIST. COLUMBIA
G: Justin Massaro - 1 A: Ahmed Elgayar - 1 Sh: 2 Players (#7, #12 - 3) Sv: Nick Aglira - 5	G: 4 Players (#8, #11, #22, #25- 1) A: Felix Angerer - 2 Sh: Felix Angerer - 4 Sv: Louis Connor - 4

TEAM STATISTICS	HOLY FAMILY	DIST. COLUMBIA
Shots (on goal)	13 (5)	10 (9)
Saves	5	4
Fouls	18	21
Corner Kicks	4	1
Offsides	0	7

full stats

Post-Game Interview

WASHINGTON, DC – After surrendering a goal in the opening minutes of action, the University of the District of Columbia men's soccer team scored four unanswered goals for a convincing, 4-1 season-opening win against Holy Family on a beautiful Friday afternoon in the nation's capital.

Under head coach Matt Thompson, UDC is 3-0 in season-opening games, as the Firebirds begin the season 1-0 and the Tigers fall to 0-1.

Four different Firebirds tallied goals, including freshman forward Felix Angerer (Business Administration – Bayreuth, Germany/Graj Minster Gymnasium) who registered a goal and two assists. Fellow freshman forward Sam Rowden (Psychology – Lincoln, England/Saint Peter Saint Paul Catholic) was credited with a goal and an assist as well.

Sophomore co-captain Louis Connor earned the win in goal in his debut for UDC with four saves and one goal allowed. HFU's Nick Aglira made five stops while allowing four goals in the loss.

Holy Family's Ahmed Elgayar took the first shot of the game right around the three-minute mark. Elgayar's shot was stopped by Connor, only to trickle right to the feet of Justin Massaro, who hammered the ball in from only five yards out for the game's first goal.

District of Columbia responded a little over seven minutes later when sophomore Elio Hernandez(Health – Germantown, MD/Northwest HS) finished off a pretty pass by Angerer immediately following a cross sent into the box by senior Bakary Coulibaly (Electrical Engineering – Hyattsville, MD/La Lumiere HS).

The Firebirds struck again less than two minutes later when Rowden rocketed a shot from about 20 yards out following a long outlet pass by Connor and through ball by Angerer.

With a little over 10 minutes left to play before halftime, Angerer netted the first goal of his career when he scored on his own rebound of a penalty kick. Angerer's goal sent the Firebirds into halftime with a comfortable, 3-1 lead.

The Firebirds sat on their 3-1 lead for much of the second half as the Tigers owned a 6-3 shot advantage in that closing period. Still, it was only UDC which netted a second half goal as the speedy junior reserve Byron Brown (Accounting – Silver Spring, MD/Pocono Mountain HS) entered the game late and almost immediately scored a breakaway goal to make it 4-1.

Next up for UDC is another home game on Sunday at 1 p.m. vs. Goldey-Beacom College. The last time these two schools met was Thompson's first game as head coach of the Firebirds, and UDC won 1-0 on September 2^nd, 2011.

Stop this rogue protein before it kills you

Control This 'Rogue Protein' Today... Or Risk Disease and Early Death     There's been a quiet revolution going on...     During the past 20 years or so, scientists have gained new understanding in the way our immune system works — how it guards us from invading microbes and wild uncontrolled cancer cell growth. Some of that research has yielded an exciting, highly effective substance derived from citrus — but not from the fruit! It's from the part most of us throw away.     This substance from oranges and grapefruit stops a "rogue protein" that most people don't know about — but that may be a major cause of deaths by cancer, heart disease, stroke and more. Your level of this rogue protein is probably a more important health marker than cholesterol and many other biomarkers that doctors and patients fret about. And the citrus breakthrough is the only known substance that helps control it.     It's not often you find a plant-based substance that offers the universal benefit and breakthrough potential of the one I'm going to talk about today... Continued below... The Secret Cure For High Blood Pressure     If you're struggling with your blood pressure, this news is going to make your day:     A German scientist has discovered that eating certain foods causes your body to retain water, which increases the volume of fluid in your circulatory system (commonly called "bloating"), thus raising the pressure in your blood vessels.     By abstaining from these foods (or cutting back), your body sheds water and the "bloat," which dramatically reduces blood pressure.     So, what are these "high blood pressure foods" you should avoid?     If you said "salty" or "fatty" … you're wrong.     Hold on to your hat — because the foods that raise blood pressure the most are some of the very foods that doctors say we should eat more of as part of a "heart-healthy, low-fat diet."     Click the link below to read how to finally get your blood pressure under control — without drugs! The Secret Cure For High Blood Pressure     This novel compound offers proven properties in blocking cancer cell aggregation, adhesion, and metastasis. And a mounting stack of evidence shows it not only protects against cancer but also a host of other diseases.     A major reason cancer is so deadly is its tendency to metastasize to other sites throughout your body. The majority of cancer deaths come from tumor cells that enter your blood and lymphatic systems and hitch a ride to your lungs, liver, bones, and elsewhere.     Till recently there's been little hope of an effective way to prevent cancers from metastasizing.     Fortunately, clinical research now shows that a food supplement called Modified Citrus Pectin (MCP) can limit tumors from spreading in men with advanced prostate cancer.1 Other research indicates it's effective against other types of cancer as well. However, please take heed: some brands of MCP are better than others, so going on the net and ordering the cheapest one is not a smart move (it seldom is for any supplement).     But before we discuss that, let's pause for a moment and talk about that "rogue protein." It's called galectin-3… A serious troublemaker     Mounting research links elevated levels of the rogue molecule to not just cancer but many other diseases, too.     At this point, the general public knows little about galectin-3, but epidemiology experts expect a whole new disease classification of "Elevated Galectin-3 Conditions" to emerge.     Published research shows that advanced cancer, chronic inflammation, organ and tissue remodeling and fibrosis all share a common culprit — excessive galectin-3. (Tissue remodeling is a repair response to injury. Fibrosis is abnormal tissue remodeling that creates excessive scar tissue within organs, causing loss of function.)     So, what do we know about this rogue protein troublemaker? More than you might think…     Galectin-3 is a beta-galactoside binding protein involved in many cellular processes. It occurs naturally in your body in small amounts. But real trouble emerges when your levels become elevated, triggering life-threatening diseases.     The role of galectin-3 in metastatic cancer has been well documented over the past couple of decades.     But scientists now know that galectin-3 is directly linked to many other serious diseases — heart attack, congestive heart failure, strokes, kidney disease, inflammation, and mortality from all causes.     A ten-year study of mortality from all causes was completed in August 2011 and involved 8,000 people. It showed that high levels of galectin-3 tripled all-cause mortality.2 That makes galectin-3 a shocking and important risk factor — more so than cholesterol, in my opinion. There's only one proven galectin-3 blocker     The only proven natural galectin-3 blocker is Modified Citrus Pectin (MCP)3 — an advanced form of citrus, derived from citrus pith — the white stuff that comes between the skin and the juicy part of the fruit you like to eat. The citrus pith is modified to a specific molecular weight and structure that allows the body to absorb it. (Note: Big Pharma is planning synthetic versions also.)     This unique structure is what gives MCP its therapeutic qualities. Eating unmodified citrus protein will not be helpful because the molecules are too large for the body to absorb.     Pectin is abundant in oranges, lemons and grapefruits, as well as apples, guavas, quince, plums and gooseberries.     The problem is that its highly branched molecules don't dissolve in liquid. In modified form, it's more easily absorbed by your digestive tract, moves into your bloodstream quickly, and once there it targets galectin-3 molecules throughout your body.     Published research has demonstrated that MCP is the only natural inhibitor of galectin-3 that controls it by binding and blocking its far-ranging harmful effects. MCP and cancer progression     Galectin-3 is over-expressed on the surface of certain cancer cells. It's 'sticky', so it allows cancer cells to accumulate before disbursing throughout your circulatory system. It's now a proven scientific fact that galectin-3s are highly capable of promoting cancer progression and metastasis.     Studies consistently show the clinical value of binding, blocking and neutralizing your circulating levels of galectin-3, which MCP is highly capable of doing.     MCP is especially useful in preventing and treating metastatic cancer — especially solid tumors such as melanoma, and prostate, colon and breast cancers.     One of the most promising studies to date shows that MCP inhibits prostate cancer metastasis. It was published in the Journal of the National Cancer Institute in 1995.     The researchers injected rats with human prostate cancer cells and divided them into four groups.     The control group received water only, and the remaining groups received water with varying concentrations of MCP. One month later, only 50 percent of the rats receiving MCP had any metastasis. But 94 percent of those fed water with no MCP had metastasis to their lungs.4 Works in humans, too     Following up on these exciting results in 1999, oncologist Dr. Stephen Strum and colleagues showed that MCP had positive effects on patients suffering from advanced prostate cancer.5     Five out of seven men with advanced prostate cancer (unable to do conventional treatment) responded positively to taking MCP daily for three months or more.6 This was confirmed using Prostate Specific Antigen Doubling Time (PSADT), which measures how fast blood levels of PSA rise. Since PSA is a marker for cancer progression or recurrence, longer PSA doubling times mean slower disease progression, which is good. Granted, it's a small observational study…     But another Phase II clinical trial showed that MCP increased the PSA doubling time in eight of the ten men whose prostate cancer had returned after conventional treatment. They took MCP for 12 months.7 This study used a particular brand of MCP, Pectasol-C®. This is the brand we recommend because it's most extensively backed by clinical research.     Other animal studies show MCP to be effective against breast, skin and liver cancers, as well as prostate cancer.8 Cancer was much less likely to spread to the lungs in mice who got MCP.     Another animal study started with melanoma cells. Those receiving MCP had notably fewer tumors spread to their lungs. When the MCP rats did get lung tumors, they were much smaller than the untreated mice.9     Scientists believe MCP makes it tough for cancer cells to break away from the main tumor, which keeps it from aggregating and spreading.     MCP also induced apoptosis (natural cell death) in various types of cancer. And it may activate T, B and NK immune system cells and induce cell death in leukemia cells.     Incidentally, if you do opt for conventional chemotherapy, you'll get dramatically better results if you use MCP as a adjunct therapy.10,11 MCP is particularly valuable for patients who want to combine alternatives with conventional treatments. Helps fight heart disease and more     MCP research is ongoing for conditions other than cancer. Here are the high points: Cardiovascular disease. Galectin-3 is linked to cardiac injury, progression to heart failure, and cardiac fibrosis. Lowering galectin-3 levels reduces fibrosis and improves outcomes.12 Inflammation is the hallmark of arteriosclerosis and galectin-3 levels contribute to inflammation. Diabetes and metabolic syndrome. Controlling your galectin-3 levels may help reduce inflammation associated with type II diabetes, metabolic disease, and insulin resistance. Fibrosis. Galectin-3 plays a central role in promoting fibrosis, and is even able to activate 'resting' fibroblasts into more active ones.13 MCP may be vital in halting that damage. Rheumatoid Arthritis. Study showed reducing galectin-3 levels also reduced arthritis and decreased pro-inflammatory cytokines.14 Inflammatory GI Conditions. MCP reduces inflammation in your gut mucosa, which can help with ulcerative colitis, Crohn's disease, Celiac disease, and gluten sensitivity.15 Liver Disease. High galectin-3 levels are linked strongly to liver fibrosis. MCP can be used as a preventive, and also post-disease, and for various types of hepatitis. Asthma. In one study, mice with lower levels of galectin-3 showed improvement in important markers. Kidney disease. Lowering galectin-3 levels was linked to a decrease in kidney fibrosis, and other signs of organ damage. It's even a potent detox agent     Heavy metals can seriously aggravate or initiate health problems. Chelation therapy has traditionally used chemicals that bind to heavy metals like lead and mercury and usher them out of your body. But intravenous chelatoin needs a clinical setting, requires a catheter in your arm, and may involve chemical side effects.     In contrast, oral MCP has been shown to bind toxins and release them via your urine.     In a 2006 study, eight healthy people were given 15 grams of MCP a day for five days, and 20 grams on day 6. Twenty-four hour urine samples were gathered on days one and six, and analyzed for toxin and nutrient excretion.     Here's what the study found… Significant increases in excretion of arsenic, mercury, cadmium, and lead between day one and day six. 150% increase in cadmium excretion. 560% increase in lead excretion. Essential mineral excretion (calcium, zinc, and magnesium) did not increase, showing that MCP didn't deplete these nutrients. This is important because conventional chelation removes healthy minerals along with toxic heavy metals.     In one case study, five patients with different diseases were each given the PectaSol-C®form of for seven months. Each experienced a decreased (average 74%) heavy metal burden, which was believed to play a key role in their recovery. FDA-approved test measures levels of galectin-3     There's now a very affordable galectin-3 blood test, covered by most insurance plans. It's approved for measuring cardiovascular disease risk and also as a biomarker for metastatic cancer. Levels above 15 ng/ml are considered high risk.     Unlike the biomarker C-reactive protein (CRP) which only indicates you have inflammation, elevated galectin-3 is recognized as an active trouble-making biomarker. And there's actually something you can do about it… take MCP.     Looking for a lab? Health Diagnostics Laboratory offers galectin-3 testing as part of its total cardiovascular panel… 804-343-2718 or www.myhdl.com. Powder or Capsules?     MCP is available in powdered and capsule form. It's best taken on an empty stomach — 30 minutes before eating, or 1 hour after.     Dosage varies by whether you're taking it at a therapeutic or maintenance level.     It's important to know that not all MCP products are made alike. The only clinically tested and researched MCP is PectaSol-C®, made by EcoNugenics.     Therapeutic: For those with concerns about cancer, cardiovascular disease, heavy metal toxicity, immune issues, or high circulating galectin-3 levels… 15 grams/day (a 5-gram scoop of powder 3x/day — or 6 capsules 3x/day).     Maintenance: For long-term health maintenance… 5 grams/day (5 gram scoop of powder once/day — or 6 capsules per day).     MCP is available through various venders online, or from these… In Canada — Promedics, www.promedics.ca In USA — EcoNugenics, Inc., www.PectinForHealth.com     I consider MCP one of the most promising supplements for cancer, fibrosis and so much else. Yet so few people know about it. So please, do pass this on to friends and loved ones. Footnotes: 1Azemar M, Hildenbrand B, Haering B, Heim ME, Unger C. Clinical benefit in patients with advanced solid tumors treated with modified citrus pectin: a prospective pilot study. Clin Med Oncol. 2007;1:73-80. 2DeBoer RA. Gelctin-3 Levels & Mortality from All Causes in the General Population: PREVEND The Prevention of Renal and Vascular End-stage Disease (PREVEND) study results presented at the European Society of Cardiology (ESC) Congress (Aug) 2011, in Paris, France. "Galectin-3, Cardiovascular Risk Factors and Outcome in the General Population." 3Kidd 1996, Nangia-Makker 2002, Olano-Martin 2003 4http://www.lef.org/magazine/mag2009/mar2009_Modified-Citrus-Pectin-Fighting-Cancer-Metastasis -Heavy-Metal-Toxicities_02.htm 5http://www.lef.org/magazine/mag2009/mar2009_Modified-Citrus-Pectin-Fighting-Cancer-Metastasis -Heavy-Metal-Toxicities_02.htm 6Strum S, Scholz M, McDermed J, McCulloch M, Eliaz I. Modified citrus pectin slows PSA doubling time: a pilot clinical trial. Paper presented at: International Conference on Diet and Prevention of Cancer; May 1999; Tampere, Finland. 7Guess BW, Scholz MC, Strum SB, et al. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis. 2003;6(4):301-4. 8Nangia-Makker et al., 2002; Platt and Raz, 1992; Liu et al., 2008. 9Platt and Raz, 1992. 10Najmeh T, Houri S, Parvin M, Firouzeh B, Arash HN, Abdolfattah S, Ebrahim H. Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU-145 and LNCaP prostate cancer cell lines. Cell Biology International 2012, Immediate Publication, doi:10.1042/CBI20110309. 11Jiang, J, Eliaz, I, Sliva, D. Synergistic and Additive Effects of Modified Citrus Pectin with Two Polybotanical Compounds, in the suppression of invasive behavior of Human Breast and Prostate Cancer Cells. Int. Cancer Therapies.2012; doi:10.1177/1534735412442369 12Psarras S, Mavroidis M, Sanoudou D, Davos CH, Xanthou G, Varela AE, et al. Regulation of adverse remodelling by osteopontin in a genetic heart failure model. Eur Heart J. 2011; 20 [Epub ahead of print] 13Galectin-3 and the Role of Modified Citrus Pectin in Cancer and Beyond, Integrative Health Practitioners Magazine 14Eliaz, Isaac. Targeting Galectin-3: A New Paradigm in Integrative Medicine 15Fowler M, Thomas RJ, Atherton J, Roberts IS, High NJ. Galectin-3 binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion. Cell Microbiol. 2006;8;1:44-54.

Health Disclaimer: The information provided above is not intended as personal medical advice or instructions. You should not take any action affecting your health without consulting a qualified health professional. The authors and publishers of the information above are not doctors or health-caregivers. The authors and publishers believe the information to be accurate but its accuracy cannot be guaranteed. There is some risk associated with ANY cancer treatment, and the reader should not act on the information above unless he or she is willing to assume the full risk. Reminder: You're getting this email because you purchased a special report or book from us, or signed up for our free newsletter and gave us permission to contact you. From time to time we'll alert you to other important information about alternative cancer treatments. If you want to update or remove your email address, please scroll down to the bottom of this page and click on the appropriate link. We're an online cancer bookstore offering Outsmart Your Cancer, Cancer Step Outside the Box, Stop Cancer Before It Starts, Natural Cancer Remedies that Work, Adios-Cancer, Cancer Breakthrough USA, Missing Ingredient For Good Health, German Cancer Breakthrough, How to Cure Almost Any Cancer for $5.15 a Day and Keep Your Gallbladder!

Obliterate that Belly Fat Now With US Sports Strength and Conditioning Boxing Conditioning Program!

Get into great shape for just about any sport, or simply get ripped with US Sports Strength and Conditioning's Boxing Conditioning Program customized just for you:

Boxing

The Boxing Programs will enhance general strength and increase muscular endurance. There are also bouts of rope jumping interspersed throughout each workout day to enhance footwork and agility. The cross-training stimulus these programs provide will enhance overall boxing ability and help to prevent injuries as well!

Throughout the length of the Boxing Program, the manipulation of the sets and repetitions for each exercise will be based on periodization concepts that involve changing the intensity and the volume of the workouts.

The starting point of the workout is based on an initial fitness level. With feedback, the actual progression of the program will follow the body's unique adaptation process to exercise. Fine tune the program to include all the exercises that feel the best!

Here is a sample:

Week 1 - Day 1 (Monday) Of Your Program	Week Difficulty: Medium
View Printer Friendly Version

Click on an Exercise Name to view a description of that exercise

Select		Exercise Name	Set and Rep Combinations
	1	Warmup and Stretch	8 minutes
	2	Video Squat	20 reps @ 240 lbs, 20 reps @ 240 lbs, 15 reps @ 240 lbs
	3	Video Dumbbell Step Up	15 reps @ 40 lbs, 12 reps @ 40 lbs
	4	Video Jump Rope General	2 Minutes
	5	Video Machine Leg Curl	15 reps @ 120 lbs, 10 reps @ 110 lbs
	6	Video Med Ball Side Throw (kneeling)	12 reps, 8 reps, 8 reps

Sign Up Now for this 12 week Sports Specific Online Program  Just 33 cents per day!

Click Here

Doctors who prescribe chemo don't tell you this

If you think cancer "experts" are hiding something...you're right!     Cancer researchers pride themselves on making great strides toward finding the causes and treatments for cancer.     And as they're supposed to in professional medical journals, they publish details about the problems they're addressing… the methodologies they use… the type of people who take part in the studies… the conclusions they reach…     Or do they? Continued below... Drink This and Cancer Comes Pouring Out of Your Body     "If I could pick only one treatment to cure my cancer, this would be it," says a top expert on alternative cancer treatments.     Research conducted by a scientist at the Detroit Institute of Cancer Research showed this is one of the world's most powerful cancer cures. Even the mainstream National Cancer Institute confirmed that this do-it-yourself treatment kills cancer cells. Then they buried the research.     Personally, I've been writing about cancer treatments for almost seven years. Out of nearly 400 that I've investigated, I haven't found an at-home treatment that's better.     It worked for Robert, age 54, who had late stage stomach cancer. His doctors told him he didn't have chance. The most they could do was buy him a little time, using four aggressive chemotherapy drugs PLUS radiation — a deadly, toxic, last-ditch treatment.     INSTEAD Robert used this non-toxic liquid and was completely cancer-free within months. The amazed doctor was forced to admit Robert's cancer was "in remission." Two years later, he was still cancer-free.     Click the link below to watch an important video presentation about this discovery... Click here and watch an important video presentation about this discovery.     When it comes to investigating chemotherapy treatments, one group of researchers doesn't think so.     This new finding comes from Princess Margaret Hospital in Toronto, Canada. A team led by Ian F. Tannock, MD, FRCPC, PhD, scoured 164 journal articles published over 16 years and made this startling discovery: The researchers were hiding information about chemotherapy drug side effects!     The group published their results on Jan. 9, 2013 on the Annals of Oncology website. According to their research, not even one-third of reports on clinical trials for breast cancer chemotherapy medications contained detailed data on side effects and adverse drug events.     I don't know about you… but I don't believe for one second that any chemo cocktail could have been THAT good!     Not only were these breast cancer drug researchers underreporting side effects—but they also went out of their way to report more positive treatment outcomes.     In other words, these studies aren't valid scientific reports. They're disguised sales pieces for chemo drugs.     Think about what this means for cancer doctors and their patients… Did someone call for a spin doctor?     Doctors are busy, just like most people. To stay current on the latest research, they don't read entire journal articles. They tend to read abstracts - brief summaries provided at the top of the articles -- to get the gist of the findings.     Dr. Tannock's group found that two-thirds of the drug studies they examined don't mention serious side effects in these summaries. This held true not only for chemotherapy studies but for cancer studies involving surgery and radiation as well.     The Canadian researchers found similar omissions in the discussion sections and results tables.     This means most doctors prescribing treatments are not aware of the full range of potential side effects. (Actually, the problem goes well beyond cancer drugs. Doctors spend little time educating patients about side effects for ANY prescription drug. It's up to you to find out for yourself.) The corrupt world of peer-reviewed journals     Dr. Tannock told Reuters about another disturbing trend they noticed in the studies they reviewed: Researchers for these breast cancer drug studies had a tendency to change the definition of success.     Specifically, Dr. Tannock said if a treatment didn't produce stellar results, some researchers just choose a different set of results to report—regardless of whether the study was designed to test them.     Just so we're clear… drug companies often provide the money to study the cancer concoctions they intend to market. So researchers are under pressure to produce glowing reports, or risk seeing research dollars disappear. Some may try to hang on to their virginity, but it seems the drug companies have no trouble finding scientists for sale.     I recently had a behind-the-scenes look at this world of peer-reviewed published research. Sometimes a big-name doctor's name is listed among the authors even though he or she didn't really do anything. A well-known doctor can supplement his income by lending his name to companies trying to get a scientific seal of approval on their products.     And lesser known, working scientists want their studies published in prestigious journals. If they frame their research in a positive light, it increases their chances for publication, additional grants, career promotion and tenure.     But this win-win deal for drug companies and the researchers who do their bidding is a sure loser for cancer patients who are kept in the dark about drug side effects. One rotten egg that made it to market…     You've probably heard drug commercials that spend maybe 55 seconds describing the benefits—then in the last five seconds a fast-talking motor-mouth comes on, the volume is turned down, and they rattle off a quick list of warnings and side effects.     These are just the dangers that are so common they feel required to tell you about them. Imagine how long the commercial would be if they included unreported side effects!     The practice of underreporting bad effects helps explain how the drug Avastin® could have made its way to pharmacies.     In February 2008, the Food and Drug Administration (FDA) gave an accelerated approval to use Avastin in combination with the cancer drug paclitaxel to treat metastatic breast cancer.     Adding Avastin supposedly prevented angiogenesis -- blood vessels growing on tumors to nourish them.     An FDA news release said the speedy approval was based on promising results from one study that suggested Avastin could extend a cancer patient's life.     Avastin's maker, Genentech, completed two additional clinical trials after the drug was approved and submitted data from those studies to the FDA. What did these results show? Minimal effect on tumor growth No evidence that patients lived any longer No indication that quality of life improved when compared to taking standard chemotherapy     In the end, the agency revoked Avastin's approval for breast cancer treatment less than three years after approving it for that use.     FDA Commissioner Dr. Margaret A. Hamburg said, "After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit in terms of delay in tumor growth that would justify those risks."     And get a load of the side effects some women experienced during the time the drug was approved for use as a breast cancer treatment… Bleeding and hemorrhaging Heart attack and heart failure High blood pressure (severe) Perforations in the nose, stomach, intestines and other body parts     Before you think warm and fuzzy thoughts about the agency revoking its use as breast cancer treatment—remember it's still on the market to treat other cancers.     What's more, Dr. Hamburg actually invited Avastin's drugmaker to TRY AGAIN stating, "I encourage Genentech to consider additional studies to identify if there are select subgroups of women suffering from breast cancer who might benefit from this drug."